Correction of HIV-associated thrombocytopenia with low doses of interferon alfa

South Med J. 1992 May;85(5):557-9. doi: 10.1097/00007611-199205000-00021.

Abstract

We have presented a case of HIV-associated thrombocytopenia successfully treated with low dose interferon alfa-2a. Increases in platelet levels were achieved within 1 week without hospitalization or surgery. Further, the patient had no systemic side effects from therapy. Zidovudine alone was ineffective in maintaining noncritical platelet counts. Interferon alfa-2a is a nonimmunosuppressive, nonsurgical therapy that can correct HIV-associated thrombocytopenia without requiring hospitalization.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • HIV Infections / complications*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage*
  • Interferon-alpha / blood
  • Male
  • Platelet Count
  • Recombinant Proteins
  • Thrombocytopenia / complications
  • Thrombocytopenia / therapy*

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins